Home » Topics » BioWorld Science

BioWorld Science
RSS

Astellas and Sutro partner to discover and develop novel immunostimulatory antibody-drug conjugates

June 28, 2022

Kuria licenses rights to SCOHIA's SCO-116 for ocular and dermatologic diseases

June 28, 2022

NCI grant supports Penn's development of intraoperative imaging technology for NSCLC

June 28, 2022

Hillstream partners with Sapien to study synergy between HSB-1216 and immune checkpoint inhibitors

June 28, 2022

Ainos reports preclinical data on low-dose oral interferon-alpha Veldona against COVID-19

June 28, 2022

Use of [89Zr]Prot-FH for neutrophil imaging during fungal infection

June 28, 2022

New pH-responsive albumin-binding ligands show targeted tumor uptake in vivo

June 28, 2022

EAN 2022: At several scales, connective landscape provides lens for neurology

June 28, 2022

RBM22 inversely correlates with prostate cancer aggressiveness

June 28, 2022

IMPACT Therapeutics synthesizes new NUAK inhibitors

June 28, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.